HIV-related haematological malignancies: a joint Series from The Lancet Haematology and The Lancet HIV
About this video
Since the earliest days of the HIV epidemic, haematological malignancies have been a defining feature of illness caused by the virus; individuals with HIV are living longer and contending with the challenges of treating cancer while on ART, now, work on haematological cancers is providing insights into how a cure for HIV might be achieved. Join Peter Hayward, Editor-in-Chief of The Lancet HIV, and the Series authors as they introduce and explore the findings from this new joint Series on HIV-related haematological malignancies from The Lancet Haematology and The Lancet HIV.
About the presenter
- The Lancet